- Home
- ITCI vs SJM Comparison
ITCI vs SJM Comparison
Compare ITCI & SJM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITCI
- SJM
- Stock Information
- Founded
- ITCI 2002
- SJM 1897
- Country
- ITCI United States
- SJM United States
- Employees
- ITCI N/A
- SJM N/A
- Industry
- ITCI Biotechnology: Pharmaceutical Preparations
- SJM Packaged Foods
- Sector
- ITCI Health Care
- SJM Consumer Staples
- Exchange
- ITCI Nasdaq
- SJM Nasdaq
- Market Cap
- ITCI 13.5B
- SJM 11.4B
- IPO Year
- ITCI N/A
- SJM N/A
- Fundamental
- Price
- ITCI $126.97
- SJM $104.66
- Analyst Decision
- ITCI Buy
- SJM Buy
- Analyst Count
- ITCI 13
- SJM 9
- Target Price
- ITCI $103.62
- SJM $126.78
- AVG Volume (30 Days)
- ITCI 5.8M
- SJM 973.6K
- Earning Date
- ITCI 02-20-2025
- SJM 02-25-2025
- Dividend Yield
- ITCI N/A
- SJM 4.12%
- EPS Growth
- ITCI N/A
- SJM N/A
- EPS
- ITCI N/A
- SJM 4.96
- Revenue
- ITCI $613,728,000.00
- SJM $8,831,200,000.00
- Revenue This Year
- ITCI $48.43
- SJM $9.23
- Revenue Next Year
- ITCI $38.10
- SJM $1.25
- P/E Ratio
- ITCI N/A
- SJM $21.12
- Revenue Growth
- ITCI 46.08
- SJM 7.76
- 52 Week Low
- ITCI $62.78
- SJM $99.81
- 52 Week High
- ITCI $128.00
- SJM $133.85
- Technical
- Relative Strength Index (RSI)
- ITCI 84.04
- SJM 44.85
- Support Level
- ITCI $126.88
- SJM $105.25
- Resistance Level
- ITCI $127.36
- SJM $109.00
- Average True Range (ATR)
- ITCI 0.44
- SJM 2.32
- MACD
- ITCI -0.90
- SJM 0.60
- Stochastic Oscillator
- ITCI 55.86
- SJM 52.77
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.
About SJM The J.M. Smucker Company
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (78% of fiscal 2024 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of Hostess and international (primarily Canada). Retail coffee is its largest category (33% of sales) with brands Folgers and Dunkin'. Pet foods (22% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from consumer foods, primarily peanut butter and jelly, through brands Jif and Smucker's. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.